Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Receivables - Net (2020 - 2026)

Alvotech's (ALVO) quarterly Receivables - Net came in at $46.6 million in Q2 2026, down 56.91% on a YoY basis from $108.1 million in Q2 2025, and down 2.6% quarter-over-quarter from $47.8 million in Q1 2026.

Analysis

Alvotech (ALVO) Receivables - Net (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Receivables - Net for 7 consecutive years, with $46.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables - Net fell 56.91% year-over-year to $46.6 million; the trailing twelve-month figure through Jun 2026 stood at $46.6 million (down 56.91% YoY), and the FY2025 full-year result was $69.7 million, down 56.47% from the prior year.
  • Receivables - Net declined to $46.6 million in Q2 2026 per ALVO's latest filing, from $47.8 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $168.3 million in Q1 2025 and bottomed at $5.3 million in Q2 2022.
  • Historically, Receivables - Net has averaged $76.4 million across 5 years, with a median of $58.8 million in 2025.
  • The sharpest annual moves came in 2024 and 2026: Receivables - Net soared 473.5% in 2024, then sank 71.59% in 2026.
  • Over 5 years, Receivables - Net stood at $33.0 million in 2022, then advanced by 25.23% to $41.3 million in 2023, then jumped by 288.01% to $160.2 million in 2024, then plunged by 56.47% to $69.7 million in 2025, then sank by 33.21% to $46.6 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $46.6 million, $47.8 million, and $69.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.58 Mn
Mar 31, 2026 47.82 Mn
Dec 31, 2025 69.74 Mn
Sep 30, 2025 160.22 Mn
Jun 30, 2025 108.10 Mn
Mar 31, 2025 168.32 Mn
Dec 31, 2024 160.22 Mn
Sep 30, 2024 77.42 Mn
Jun 30, 2024 93.52 Mn
Mar 31, 2024 41.25 Mn
Dec 31, 2023 41.29 Mn
Jun 30, 2023 16.31 Mn
Dec 31, 2022 32.97 Mn
Jun 30, 2022 5.30 Mn
Dec 31, 2021 29.40 Mn
Dec 31, 2020 583,000.00